Absci and AMD Announce Collaboration and Strategic Investment …
4 days ago · $20 Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct Accelerators and ROCm Software VANCOUVER, Wash., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug
Absci and AMD Announce Collaboration and Strategic Investment …
3 days ago · $20 Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct Accelerators and ROCm SoftwareVANCOUVER, Wash ...
Absci Corporation and Owkin Announce Strategic Partnership for …
1 day ago · Absci Corporation and Owkin have announced a partnership to combine their advanced AI platforms for the rapid discovery and design of novel therapeutics. Absci, known for its generative AI in drug ...
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
3 days ago · Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery. AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company ...
Absci Corporation Announces Strategic Collaboration with AMD
3 days ago · Absci partners with AMD, investing $20 million to enhance AI-driven drug discovery and antibody design capabilities. Quiver AI Summary. Absci Corporation has announced a strategic partnership with ...
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
3 days ago · AMD collaborates with Absci for AI drug discovery advancements. AMD makes a $20 million investment to boost drug research. The partnership will leverage AMD Instinct accelerators and ROCm software ...
Almirall and Absci announce AI drug discovery partnership to …
Nov 14, 2023 · The partnership combines Absci’s Integrated Drug Creation™ platform with Almirall’s dermatological expertise with the goal of delivering life-changing medicines to patients, marking another step forward in AI drug creation.
Press Releases - Absci
Almirall and Absci Announce AI Drug Discovery Partnership to Rapidly Develop Novel Treatments for Dermatological Diseases
Absci and Owkin Synergize Leading TechBio Platforms to Advance ...
1 day ago · VANCOUVER, Wash. and PARIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to ...
Absci and AMD Team Up to Revolutionize Drug Discovery with AI
4 days ago · Absci Corporation, a trailblazer in generative AI for drug creation, has announced a pivotal collaboration with AMD, leveraging AMD Instinct™ accelerators and ROCm™ software to power Absci's AI-driven drug discovery processes.Central to this partnership is AMD's $20 million private investment in public equity (PIPE), highlighting a surging demand for innovative applications of AI in biopharma.